Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

An application was made by Immuno to vary the product licence in respect of Kryobulin to allow European plasma to be sold in red packs and US plasma to be sold in cheaper blue packs.

Published on: 22 July, 2024

An application by Immuno to vary the product licence in respect of Kryobulin to allow European plasma to be sold in red packs and US plasma to be sold in cheaper blue packs was approved.

Published on: 22 July, 2024

The Department of Health and Social Security informed Immuno approval had been granted to vary the product licence in respect of Kryobulin to allow European plasma in be sold in red packs and US plasma to be sold in cheaper blue packs.

Published on: 22 July, 2024

Licences for heat-treated Hemofil and Factorate were refused.

Published on: 22 July, 2024

FDA recommendation of steps including avoiding use of high risk plasma in US blood products was published.

Published on: 22 July, 2024

Paper from Dr Spence Galbraith recommended suspending importation of US blood products.

Published on: 22 July, 2024

The CSM endorsed the recommendation by the CSM(B) not to recommend action to stop continued importation of commercial concentrates.

Published on: 22 July, 2024

CSM(B) decided not to recommend action to stop continued importation of commercial concentrates.

Published on: 22 July, 2024

It was confirmed that import of factor products made from higher risk pre-March plasma would continue.

Published on: 22 July, 2024

CSM requested the Licensing Authority to invite early applications for licence variations to permit distribution and sale of heat-treated concentrates.

Published on: 22 July, 2024

Dr Yellowlees sent a 'Dear Doctor' letter to all Regional Medical Officers saying that collections from prisons could continue despite the higher risk of Hepatitis B if all donations were subjected to more sensitive Hepatitis B tests.

Published on: 22 July, 2024

Dr Walford wrote in a DHSS minute that NANBH could "be rapidly fatal" and "lead to progressive liver damage".

Published on: 22 July, 2024

Dr Gunson warned DHSS civil servants that there could be "considerable publicity [...] concerning the safety of American Factor VIII"

Published on: 22 July, 2024

The line "no conclusive proof" first appeared in a briefing note to the Prime Minister.

Published on: 22 July, 2024

Dr Galbraith wrote to the DHSS recommending the withdrawal of US blood products due to the risk of AIDS transmission.

Published on: 24 September, 2024

The Council of Europe's Committee of Ministers' resolution recommending "all necessary steps and measures with respect to" AIDS be taken was adopted.

Published on: 22 July, 2024

The publication of the leaflet "AIDS and how it affects blood donors" was announced.

Published on: 22 July, 2024

The Expert Advisory Group on AIDS had its first meeting.

Published on: 22 July, 2024

The second leaflet, titled "AIDS; important new advice for blood donors", was made available to Regional Transfusion Centres.

Published on: 22 July, 2024

It was discovered that heat will inactivate hepatitis virus (in albumin).

Published on: 22 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 1987
  • Page 1988
  • Page 1989
  • Page 1990
  • Current page 1991
  • Page 1992
  • Page 1993
  • Page 1994
  • Page 1995
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.